Sandra Levy
ARTICLES BY THIS AUTHOR
- 6/9/2022
Giant to open 2 stores in Philadelphia
Two new store openings add to The Giant Co.'s significant growth in the greater Philadelphia area over the past year. - 6/9/2022
BD to acquire Parata Systems
Parata provides BD access to a new $600 million pharmacy automation market segment that is expected to grow approximately 10% annually to $1.5 billion in the United States alone over 10 years, according to the company. - 6/9/2022
Walmart, Avanlee Care help families coordinate grocery needs for aging loved ones
The all-in-one care app for families caring for a remote senior adds Walmart grocery delivery to its support for seniors and caregivers. - 6/9/2022
Alembic intros 2 generics
Alembic's latest generic offerings are entacapone tablets, nystatin and triamcinolone acetonide ointment. - 6/9/2022
NACDS to host listening sessions prior to White House conference on hunger, nutrition, health
The first session, for NACDS-member retailers, takes place June 23. The second session, for NACDS-member suppliers, occurs July 11. - 6/9/2022
New Jersey pharmacist opens nonprofit pharmacy for the uninsured
Ritesh Shah Charitable Pharmacy in Red Bank, N.J., offers medications, immunizations, health education and counseling. - 6/8/2022
NACDS, 93 groups urge continued access to pandemic-related services at pharmacies
A letter from the groups sent to the Biden administration requests that PREP Act authorities remain in place through Oct. 1, 2024. - 6/8/2022
Albertsons, Pacvue Partners give brands opportunity to connect with customers
CPG advertisers and their agencies can now leverage Pacvue to create, execute and manage sponsored product advertising campaigns on Albertsons' Retail Media Network. - 6/8/2022
Camber launches generic Pepcid
The medication is indicated for the treatment of active duodenal ulcer, active gastric ulcer and symptomatic nonerosive gastroesophageal reflux disease. - 6/8/2022
FDA advisory committee recommending EU authorization of Novavax COVID-19 vaccine
If emergency use authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine available in the United States.
